Dr Kevin Spelman is a molecular biologist, phytochemist and clinician who has worked with Cannabis, as well as many other medicinal plants, in the field, in the clinic, in laboratory settings and human trials. He is a past National Institutes of Health postdoctoral fellow, where he studied cannabinoid signaling and was the first researcher to demonstrate cannabinoid ligands in Zanthoxylum spp. He was also a Marie Curie research fellow in the European Union investigating the effects of medicinal plants on malaria.
Dr Spelman has also advised the White House Commission on Complementary and Alternative Medicine under the Clinton administration. In addition, he worked with the Department of Defense on specific therapeutic outcomes using natural products.
His research history includes investigating brain and ovarian cancer, clinical investigations, immunological studies and chemical analysis on multiple plants. International research has included the analysis of nutrient levels in teenage women in West Africa, working with children with neurological disorders in Central America and researching medicinal plants active against malaria in Paris.
Dr Spelman has been an adjunct assistant professor at Massachusetts College of Pharmacy and Health Sciences, an adjunct professor of botanical medicine at National University of Natural Medicine and a distinguished lecturer at Maryland University of Integrative Health.
Dr Spelman has published over two dozen scientific papers on medicinal plants as well as six chapters. Besides research, Dr. Spelman has considerable experience in coordinated new product development, analytical and QC guidelines, research activity and educational curriculums for industry and universities over the last 30 years.